Shortage of chemotherapeutic agents in Iraq and outcome of childhood acute lymphocytic leukemia, 1990-2002

New England Journal of Medicine

Volumn 359, Issue 4, 2008, Pages 435-437

  Frangoul, Haydar ^a   Al Jadiry, Mazin F ^b   Shyr, Yu ^a   Ye, Fei ^a   Shakhtour, Bashar ^a   Al Hadad, Salma A ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHILD WELFARE; CHILDHOOD LEUKEMIA; CONFIDENCE INTERVAL; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; IRAQ; LETTER; LEUKOCYTE COUNT; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; TIME SERIES ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 47949124902     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0803444     Document Type: Letter

References (4)

1. Akunjee M, Ali A. Healthcare under sanctions in Iraq: an elective experience. Med Confl Surviv 2002;18:249-57.
2. Sansom C. The ghost of Saddam and UN sanctions. Lancet Oncol 2004;5:143-5.
3. Chessells JM, Bailey CC, Richards S. MRC UKALL X: the UK protocol for childhood ALL: 1985-1990. Leukemia 1992;6 Suppl 2:157-61.
4. Kalmanti M, Karamolegou K, Mikraki V, et al. Efficacy and toxicity of UKALL-X in childhood ALL. Med Pediatr Oncol 1988;16:390-1. abstract.